about
Gene-environment interactions in human health: case studies and strategies for developing new paradigms and research methodologiesEpigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated HepatocarcinogenesisExport of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring CellsMicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersHepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceInterplay Between Metabolism and Oncogenic Process: Role of microRNAsDeciphering Asthma Biomarkers with Protein Profiling TechnologyHemostatic disorders of the menopausal period: the role of microRNAMicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeuticsExtracellular microRNAs as Biomarkers in Human Disease'Micro-managers' of hepatic lipid metabolism and NAFLDEpigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetesMicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseInfluence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesHypothalamic miRNAs: emerging roles in energy balance controlThe two faces of miR-29From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportP53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapyNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeGenetic and epigenetic control of metabolic healthGender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese PigsDeletion of microRNA-80 activates dietary restriction to extend C. elegans healthspan and lifespanStructural insights of non-canonical U*U pair and Hoogsteen interaction probed with Se atomMolecular Pathogenesis of NASHEpigenetics and Cellular MetabolismMicroRNA-29b promotes the adipogenic differentiation of human adipose tissue-derived stromal cellsAntidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesisBile acid signaling in metabolic disease and drug therapyXylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db MicemiR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injuryIdentification of miR-26a as a target gene of bile acid receptor GPBAR-1/TGR5MicroRNAs: history, biogenesis, and their evolving role in animal development and diseaseMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaArsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?Sterol Regulatory Element-Binding Proteins (SREBP) signallingThe influence of metabolic imbalances and oxidative stress on the outcome of critically ill polytrauma patients: a review.microRNA in the development of diabetic complications.Helicobacter pylori-induced alteration of epithelial cell signaling and polarity: a possible mechanism of gastric carcinoma etiology and disparityHepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?
P2860
Q21131232-35BE4BDD-6D3F-4585-865D-9AE17FBF1399Q26739018-E954675C-FA50-4585-8C29-2627A4343379Q26744487-DE2A1258-D7AA-4EAD-9873-E0179E7CB374Q26745980-C340711F-B53D-4C33-BE3D-ED1B0798241CQ26752622-A81F6E5A-255B-48EB-B3B7-FBA759D64E6FQ26765039-07CEB4CF-17E1-4120-9A95-CF1108D8D3C1Q26770381-10C2A003-EC93-4DD1-AF68-32BF40401ABDQ26783095-02FBD490-F8CA-4390-9E74-05F7CD789A55Q26795566-482A29DD-9F73-4548-912E-5563BDF9E212Q26796668-C3BE1F2C-A61B-429D-B656-1AA929B7C3EAQ26797421-BB7853AD-25DE-4C0E-99E9-42D70C7C165EQ26801228-B243EA19-CDF8-44A1-8D3A-AC14604FB290Q26823288-35F0C35F-C4E9-4FF7-9FEB-C679E47D516BQ26852606-AB439850-A5BE-4BE1-941C-B1D73EE4AA4CQ26865641-81EA3B56-E0B7-4363-AC73-4EA6F6C2EB92Q26865728-634C6A7B-F7CB-4322-8AB1-7BAD7E43E879Q26996481-AF737C2D-654A-4348-AEE8-4E118E46DD66Q26997647-D69BA4AB-4FB6-446C-BCE7-F19D16BF728DQ27011547-FAAEFBAF-0B38-40B6-BF66-BF91E04FA356Q27015035-59B6842C-BCC4-4106-988D-A6792CBE0016Q27026287-A7464415-91D2-494A-B396-4A15381C1ACCQ27303508-406CE6FE-9703-4157-B1B8-952320ACD029Q27320578-BFB36269-44A8-42C4-86A1-DC7D72525B33Q27679886-40085AFE-677B-4FBA-894E-22E469377976Q28071265-5043B6D3-E7FF-4923-B5CD-5EA097DFBA87Q28073039-7CAFAED2-B917-46D4-B240-12BFEDE9EF0DQ28116029-7DB5A08B-C0E9-4E7C-8B1A-5A1897AFFAD0Q28119160-23C28CE7-D909-46D6-9274-914CCEB6E8FBQ28244875-F8E30676-3502-4C33-AE72-C9B65A7ECF4BQ28354289-F795DD1F-6FE9-4EF1-95D6-BF2CB583D8A5Q28395772-442E6732-1302-444B-B8B7-AA69DF19B2CCQ28548670-D1285241-8A71-4AE4-AD0E-133468E7B77DQ28657834-41C45FCE-EBC3-4A17-AA44-67AF2BA2115BQ28658442-23354CFD-A42D-4D24-A513-38797DD47C46Q29248177-22C01C4D-1639-4BCC-8AA5-FB0E16A9667EQ30225458-7521AEFB-0C20-4F52-AF0C-F9AA22BFE227Q30235314-474C0E7A-B361-43FD-9D09-EB20A44BF307Q30353835-E0F9AD00-189C-4E0F-8CF9-5E2584958A13Q30412040-2547111E-C716-4B63-97D0-0F91DF09EBA0Q30456435-C3D03686-CBFD-4794-B38E-1988C77E9A55
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNAs in metabolism and metabolic disorders
@ast
MicroRNAs in metabolism and metabolic disorders
@en
type
label
MicroRNAs in metabolism and metabolic disorders
@ast
MicroRNAs in metabolism and metabolic disorders
@en
prefLabel
MicroRNAs in metabolism and metabolic disorders
@ast
MicroRNAs in metabolism and metabolic disorders
@en
P2860
P356
P1476
MicroRNAs in metabolism and metabolic disorders
@en
P2093
Anders M Näär
Veerle Rottiers
P2860
P2888
P304
P356
10.1038/NRM3313
P577
2012-03-22T00:00:00Z
P6179
1009036984